J. Annereau

发表

Comparing cDNA and oligonucleotide array data: concordance of gene expression across platforms for the NCI-60 cancer cells

Fuad G. Gwadry, J. Weinstein, Lawrence H. Smith, 2003, Genome Biology.

P-glycoprotein, expressed in multidrug resistant cells, is not responsible for alterations in membrane fluidity or membrane potential.

M. Gottesman, J. Annereau, Xing-jie Liang, 2003, Cancer research.

Agonists of prostaglandin E2 receptors as potential first in class treatment for nephronophthisis and related ciliopathies

J. Annereau, P. C. Rodriguez, R. Salomon, 2022, Proceedings of the National Academy of Sciences of the United States of America.

Physalin B, a novel inhibitor of the ubiquitin-proteasome pathway, triggers NOXA-associated apoptosis.

J. Annereau, C. Bailly, L. Créancier, 2008, Biochemical pharmacology.

F14512, a potent antitumor agent targeting topoisomerase II vectored into cancer cells via the polyamine transport system.

J. Annereau, C. Bailly, J. Barret, 2008, Cancer research.

Prostaglandin E1 as therapeutic molecule for Nephronophthisis and related ciliopathies

J. Annereau, P. C. Rodriguez, R. Salomon, 2022, bioRxiv.

Principal expression of two mRNA isoforms (ABCB 5alpha and ABCB 5beta ) of the ATP-binding cassette transporter gene ABCB 5 in melanoma cells and melanocytes.

M. Gottesman, G. Szakács, J. Annereau, 2005, Pigment cell research.

Cytotoxicity and cell death mechanisms induced by the polyamine-vectorized anti-cancer drug F14512 targeting topoisomerase II.

J. Annereau, C. Bailly, A. Kruczynski, 2011, Biochemical pharmacology.

Potential mechanisms of resistance to microtubule inhibitors.

J. Annereau, J. Barret, M. Kavallaris, 2008, Seminars in oncology.

Novel tetra-acridine derivatives as dual inhibitors of topoisomerase II and the human proteasome.

J. Annereau, C. Bailly, L. Créancier, 2007, Biochemical pharmacology.

Analysis of ABC transporter expression in drug-selected cell lines by a microarray dedicated to multidrug resistance

Weinstein, W. Reinhold, Y. Pommier, 2004 .

F14512, a polyamine-vectorized anti-cancer drug, currently in clinical trials exhibits a marked preclinical anti-leukemic activity

J. Annereau, C. Bailly, L. Créancier, 2013, Leukemia.

Different roles for K+ channels in cisplatin-resistant cell lines argue against a critical role for these channels in cisplatin resistance.

M. Gottesman, G. Szakács, J. Annereau, 2005, Anticancer research.

Synthesis and biological evaluation of (-)-6-O-desmethylcryptopleurine and analogs.

J. Annereau, C. Bailly, A. Kruczynski, 2015, Bioorganic & medicinal chemistry letters.

Synthesis and biological evaluation of bengacarboline derivatives.

J. Annereau, C. Bailly, J. Barret, 2008, Bioorganic & Medicinal Chemistry Letters.

Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells.

John N Weinstein, Mark Reimers, Gergely Szakács, 2004, Cancer cell.

Regulation of melanocortin 1 receptor expression at the mRNA and protein levels by its natural agonist and antagonist

J. Annereau, V. Hearing, G. Costin, 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

A New N-Channel Maximum Entropy Method in NMR for Automatic Reconstruction of "Decoupled Spectra" and J-Coupling Determination

Véronique Stoven, Marc-André Delsuc, Jean-Philippe Annereau, 1997, J. Chem. Inf. Comput. Sci..

F14512, a polyamine-vectorized inhibitor of topoisomerase II, exhibits a marked anti-tumor activity in ovarian cancer.

J. Annereau, C. Bailly, A. Kruczynski, 2016, Cancer letters.

A fluorescent biomarker of the polyamine transport system to select patients with AML for F14512 treatment.

J. Annereau, C. Bailly, J. Barret, 2010, Leukemia research.

Synthesis of conjugated spermine derivatives with 7-nitrobenzoxadiazole (NBD), rhodamine and bodipy as new fluorescent probes for the polyamine transport system.

J. Annereau, C. Bailly, J. Barret, 2009, Bioorganic & medicinal chemistry letters.

Analysis of ATP-Binding Cassette Transporter Expression in Drug-Selected Cell Lines by a Microarray Dedicated to Multidrug Resistances⃞

John N Weinstein, Yves Pommier, Gergely Szakács, 2004, Molecular Pharmacology.

Antitumor activity of pyridoisoquinoline derivatives F91873 and F91874, novel multikinase inhibitors with activity against the anaplastic lymphoma kinase

J. Annereau, C. Bailly, A. Marchand, 2009, Anti-cancer drugs.

Melanoma Chemotherapy Leads to the Selection of ABCB5-Expressing Cells

J. Annereau, B. Gomes, J. Gairin, 2012, PloS one.

Principal expression of two mRNA isoforms (ABCB5α and ABCB5β) of the ATP-binding cassette transporter gene ABCB5 in melanoma cells and melanocytes

M. Gottesman, G. Szakács, J. Annereau, 2005 .

CD10 expression by melanoma cells is associated with aggressive behavior in vitro and predicts rapid metastatic progression in humans.

P. Brousset, J. Annereau, N. Meyer, 2013, Journal of dermatological science.

Triptolide is an inhibitor of RNA polymerase I and II–dependent transcription leading predominantly to down-regulation of short-lived mRNA

J. Annereau, D. Cussac, C. Bailly, 2009, Molecular Cancer Therapeutics.

Cystic fibrosis transmembrane conductance regulator: the NBF1+R (nucleotide-binding fold 1 and regulatory domain) segment acting alone catalyses a Co2+/Mn2+/Mg2+-ATPase activity markedly inhibited by both Cd2+ and the transition-state analogue orthovanadate.

J. Annereau, P. Pedersen, Y. Ko, 2003, The Biochemical journal.

Repurposing small molecules for Nephronophthisis and related renal ciliopathies.

J. Annereau, S. Saunier, Alexandre Benmerah, 2023, Kidney international.

A novel model for the first nucleotide binding domain of the cystic fibrosis transmembrane conductance regulator

J. Annereau, B. Tümmler, J. Cassiman, 1997, FEBS letters.

therapy products gene and protein cystic fibrosis and inducing a glutathione transporter function

J. Annereau, G. Lenoir, J. Lallemand, 1997 .

Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

Mark S. Anderson, P. Gregersen, R. Nussbaum, 2021, Science Immunology.

A genotype-to-phenotype approach suggests under-reporting of single nucleotide variants in nephrocystin-1 (NPHP1) related disease (UK 100,000 Genomes Project)

A. Need, J. Annereau, M. Bleda, 2023, Scientific reports.

Nucleotide-binding domain 1 of cystic fibrosis transmembrane conductance regulator production of a suitable protein for structural studies.

J. Annereau, E. Miclet, J. Lallemand, 2000, European journal of biochemistry.